The MM+M Podcast is Medical Marketing + Media’s show about healthcare marketing writ large. Each week, hosts Marc Iskowitz and Larry Dobrow — senior editors at the publication — interview the executives commercializing brands, the agencies supporting launches, and other fascinating guests from in and around the industries of pharma, biotech, med-tech ad-tech and health media.
MM+M Podcast 5.17.22: Will abortion marketing spike if Roe v. Wade is rolled back?
With SCOTUS poised to strike down Roe v. Wade, telemedicine abortion providers are ramping up their communication about safe access.
MM+M Podcast 5.11.22: Highlights from MM+M Transform 2022
From the opening keynote to the closing one, here are audio snippets from the full MM+M Transform program.
MM+M Podcast 5.3.22: Why pharma’s “pivot to digital” resulted in a flood of failed digital product launches
Pharma’s approach to life post-COVID was to digitize paper sales aids, which led to a flood of failed digital product launches. This week’s guests discuss the findings.
MM+M Podcast 4.26.22: Why healthcare marketing needs to get a whole lot stickier
Dr. Stephen Klasko talks about the keys to adapting marketing to the new era of “care anywhere” and to patients’ increasingly digital lifestyle.
MM+M Podcast 4.20.22: Will federal legalization undercut the medical cannabis industry?
Tremaine Wright, chair of the New York State Cannabis Control Board, talks about the implications for medical cannabis and how communications are critical growing the industry.
MM+M Podcast 4.12.22: How to advance health equity in the Hispanic community
A recent study revealed significant cultural differences in the way Hispanics deal with their health. Amy Gomez, SVP of diversity strategy at Klick Health, discusses the findings.
MM+M Podcast 4.5.22: Novartis launches a Netflix-style video hub. Can it overcome doctors’ virtual fatigue?
Novartis recently launched a three-year pilot of Evermed’s Netflix-like video hub for engaging doctors. Will it satisfy doctors’ desire for personalized content?
MM+M Podcast 3.29.22: Tech-equity for healthcare marketers
Chris Hemphill, VP of applied AI and growth for Actium Health, talks about mitigating bias in data and driving equitable patient communications.
Health-data 1:1: Adobe’s Frederik Bay on personalizing patients’ digital journey
At this month’s ViVE health-tech event, MM+M’s Marc Iskowitz sat down with Adobe’s Frederik Bay to get his take on how the company’s recent decision to extend its experience cloud into healthcare may impact patients’ digital journey.
Health-data 1:1: Google Cloud’s Alissa (Hsu) Lynch on improving the consumer experience with healthcare
At this month’s ViVE health-tech event, MM+M’s Marc Iskowitz sat down with Google Cloud’s Alissa (Hsu) Lynch for her take on improving the consumer experience with healthcare.
Health-data 1:1: KKR’s Christopher McFadden on where PE is placing its bets in healthcare
At last week’s ViVE health-tech event, MM+M’s Marc Iskowitz sat down with KKR’s Christopher McFadden to discuss how private equity firms are investing in health marketing agencies.
Health data 1:1: Mayo Clinic’s Vish Anantraman on navigating a ‘post-EMR world’
At last week’s ViVE conference, MM+M’s Marc Iskowitz sat down with Vish Anantraman, CTO for the Mayo Clinic, to discuss how integration of health data and maturation of technical standards are leading to a “post-EMR world.”
Health data 1:1: Anthem’s Ashok Chennuru on privacy and ownership of patient claims data
At last week’s ViVE conference, MM+M’s Marc Iskowitz sat down with Ashok Chennuru, chief data and insights officer for Anthem, to discuss privacy and ownership of patient claims data, and more.
Health-data 1:1: Micky Tripathi on the federal information-blocking ban
At last week’s ViVE conference, MM+M’s Marc Iskowitz sat down with Micky Tripathi, the national coordinator of health IT for HHS, to discuss the federal information-blocking ban and more.
MM+M Podcast 3.9.22: Health-data checkup from a payer, provider and policy maker
This week’s MM+M Podcast finds Marc Iskowitz in conversation with three speakers at the ViVE health-tech event.
MM+M Podcast 2.28.22: How patients are upending the rare disease paradigm
Craig Martin, CEO of rare disease advocacy group Global Genes, explains the perils and pitfalls to the patient-led revolution around rare disease therapeutics.
MM+M Podcast 2.22.22: It’s Robert Califf’s FDA 2.0
Peter Pitts, a former FDA associate commissioner, weighs in on Dr. Robert Califf’s nomination as the FDA’s chief.
MM+M Podcast 2.15.22: The TikTokker who’s tackling racism in medicine, one video at a time
It’s no wonder TikTok named third-year medical student Joel Bervell its 2021 voice of change; his videos highlight racial bias in medicine and tackle decades-old disparities.
MM+M Podcast 2.8.22: The metaverse for healthcare marketers
Direct-to-avatar ads are taking their place alongside traditional DTC as the metaverse takes shape — and more brands take notice.
MM+M Podcast 2.1.22: Using telehealth to speed access to COVID treatments
Can virtual care companies get the newly authorized COVID-19 antiviral treatments to patients faster? Former ER doc Tim Peck, who started two telehealth firms and is now health director for design firm IDEO, talks about the potential.
